XXII / 22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines

22nd Century Group's (XXII) VLN cigarettes represent a remarkable breakthrough as the first and only combustible cigarettes that the FDA has authorize more_horizontal

22nd Century (XXII) is embarking on a strategic journey to unlock the full potential of its tobacco assets. This reflects the company's commitment to more_horizontal

22nd Century (XXII) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive t more_horizontal

22nd Century Group's stock price increased by 87% last week, following a 1:15 reverse split in early July; the company's valuation has improved since more_horizontal

22nd Century Group (XXII) expands its VLN offerings in Montana by adding Town Pump convenience stores to its product distribution channel. more_horizontal

22nd Century Group (XXII) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to l more_horizontal

BUFFALO, N.Y., May 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving healt more_horizontal

22nd Century Group, Inc. (XXII) Q4 2022 Earnings Conference Call March 9, 2023 10:00 AM ET Corporate Participants Matt Kreps - Investor Relations Jim more_horizontal